644.41MMarket Cap-5640P/E (TTM)
12.510High12.170Low416.45KVolume12.470Open12.260Pre Close5.12MTurnover1.31%Turnover RatioLossP/E (Static)52.65MShares17.58052wk High2.66P/B388.81MFloat Cap3.35052wk Low--Dividend TTM31.77MShs Float71.580Historical High--Div YieldTTM2.77%Amplitude3.350Historical Low12.302Avg Price1Lot Size
Stoke Therapeutics Stock Forum
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet